Use of nonsteroidal anti-inflammatory drugs that elevate cardiovascular risk

Aspirin users had statistically significant reduced risks of incidence of HCC (RR = ; 95% CI = to ) and mortality due to CLD (RR = ; 95% CI = to ) compared to those who did not use aspirin. In contrast, users of nonaspirin NSAIDs had a reduced risk of mortality due to CLD (RR = ; 95% CI= to ) but did not have lower risk of incidence of HCC (RR = ; 95% CI = to ) compared to those who did not use nonaspirin NSAIDs. The risk estimates did not vary in statistical significance by frequency (monthly, weekly, daily) of aspirin use, but the reduced risk of mortality due to CLD was statistically significant only among monthly users of nonaspirin NSAIDs compared to non-users.

Use of nonsteroidal anti-inflammatory drugs that elevate cardiovascular risk

use of nonsteroidal anti-inflammatory drugs that elevate cardiovascular risk

Media:

use of nonsteroidal anti-inflammatory drugs that elevate cardiovascular riskuse of nonsteroidal anti-inflammatory drugs that elevate cardiovascular riskuse of nonsteroidal anti-inflammatory drugs that elevate cardiovascular riskuse of nonsteroidal anti-inflammatory drugs that elevate cardiovascular riskuse of nonsteroidal anti-inflammatory drugs that elevate cardiovascular risk

http://buy-steroids.org